Quarterly report pursuant to Section 13 or 15(d)

Earnings per Share (Tables)

v3.23.3
Earnings per Share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Income Per Share of Common Stock

The following table sets forth the computation of basic and diluted net income per share of common stock:

 

 

 

For the Three Months
Ended September 30,

 

 

For the Nine Months
Ended September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Net income available to common stockholders

 

$

19,991

 

 

$

23,494

 

 

$

28,990

 

 

$

54,635

 

Dividends on redeemable preferred stock

 

 

 

 

 

1,449

 

 

 

 

 

 

 

Changes in fair value of Ares Put Option (See Note 10)

 

 

 

 

 

(2,425

)

 

 

 

 

 

(1,894

)

Net income available to common stockholders after assumed
  conversions

 

$

19,991

 

 

$

22,518

 

 

$

28,990

 

 

$

52,741

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding — Basic

 

 

118,389

 

 

 

120,074

 

 

 

119,505

 

 

 

121,950

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

  Restricted share units

 

 

1,903

 

 

 

1,182

 

 

 

1,097

 

 

 

618

 

  Ares Put Option

 

 

 

 

 

757

 

 

 

 

 

 

959

 

  Redeemable preferred stock

 

 

 

 

 

8,375

 

 

 

 

 

 

 

Weighted average common shares outstanding — Diluted

 

 

120,292

 

 

 

130,388

 

 

 

120,602

 

 

 

123,527

 

Net income per share available to common stockholders
   — Basic

 

$

0.17

 

 

$

0.20

 

 

$

0.24

 

 

$

0.45

 

Net income per share available to common stockholders
   — Diluted

 

$

0.17

 

 

$

0.17

 

 

$

0.24

 

 

$

0.43

 

Schedule of Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share

The following potential shares of common stock have been excluded from the computation of diluted net income per share because their effect would have been antidilutive:

 

 

 

As of September 30,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Stock options

 

 

1,306

 

 

 

897

 

Ares warrants

 

 

1,100

 

 

 

1,100

 

Public and Private warrants

 

 

17,333

 

 

 

17,333